Healthy volunteers test new Drug's safety in Early-Stage trial
NCT ID NCT01787747
First seen Apr 30, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This early-phase study tested the safety and how the body processes AVP-786 in 48 healthy adult men. Participants received single or multiple doses of the drug or a placebo. The goal was to gather information on drug levels and side effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.